Loading ETF profile…
The fund primarily allocates its capital to the common stock of companies within the broad healthcare sector, specifically targeting businesses engaged in pharmaceuticals, biotechnology, healthcare services, health technology, medical technology, and life sciences. The adviser seeks out industry leaders in these areas whose potential for future growth, both in scale and longevity, is believed to be underestimated by the market. Under typical market conditions, a minimum of 80% of the fund's assets will be invested in the equity securities of such healthcare-related enterprises.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| LLY | ELI LILLY AND COMPANY | 8.19% | $740.58K |
| ABBV | ABBVIE INC COMMON STOCK | 7.95% | $719.01K |
| UNH | UNITEDHEALTH GROUP INC | 6.43% | $581.07K |
| JNJ | JOHNSON & COMMON | 4.92% | $445.15K |
| MRK | MERCK & CO INC COMMON | 4.78% | $432.17K |
| AZN.L | ASTRAZENECA PLC COMMON | 4.20% | $379.81K |
| TMO | THERMO FISHER SCIENTIFIC | 3.35% | $302.69K |
| BMY | BRISTOL-MYERS SQUIBB CO | 3.16% | $285.41K |
| CVS | CVS HEALTH CORP COMMON | 3.13% | $283.18K |
| ABT | ABBOTT LABORATORIES | 2.78% | $251.21K |
| ROP.SW | ROCHE HOLDING AG COMMON | 2.70% | $243.72K |
| SYK | STRYKER CORP COMMON | 2.69% | $242.88K |
| — | NOVO NORDISK A/S COMMON | 2.68% | $242.26K |
| GSK.L | GSK PLC COMMON STOCK GBP | 2.50% | $226.36K |
| ISRG | INTUITIVE SURGICAL INC | 2.22% | $200.73K |
| DHR | DANAHER CORP COMMON | 2.18% | $197.37K |
| — | ARGENX SE COMMON STOCK | 2.14% | $193.66K |
| ABC | CENCORA INC COMMON STOCK | 1.91% | $172.82K |
| EW | EDWARDS LIFESCIENCES | 1.83% | $165.86K |
| BIIB | BIOGEN INC COMMON STOCK | 1.67% | $151.00K |
| NOVN.SW | NOVARTIS AG COMMON STOCK | 1.60% | $144.41K |
| CAH | CARDINAL HEALTH INC | 1.57% | $142.04K |
| UCB.BR | UCB SA COMMON STOCK EUR | 1.48% | $133.62K |
| IQV | IQVIA HOLDINGS INC | 1.40% | $126.34K |
| CNC | CENTENE CORP COMMON | 1.39% | $126.07K |